Literature DB >> 26609336

Minimal fat renal angiomyolipoma with lymph node involvement: A case report and literature review.

Guangxiang Liu1, Dongwei Yao1, Shiwei Zhang1, Xiaozhi Zhao1, Tieshi Liu1, Xiaogong Li1, Hongqian Guo1.   

Abstract

Renal angiomyolipomas (AML), consisting of fatty tissue, blood vessels, and smooth muscular cells in various proportions, is a relatively common benign renal neoplasm. Simultaneous involvement of the kidney and lymph nodes is uncommon and might be confused with an advanced renal cancer. AML is divided into minimal fat AML and fat-predominant AML. However, minimal fat AML with lymph node involvement is extremely rare and difficult to differentiate from RCC on images. We report such a case and review the literature.

Entities:  

Year:  2015        PMID： 26609336      PMCID： PMC4641881          DOI： 10.5489/cuaj.2749

Source DB:  PubMed          Journal:  Can Urol Assoc J        ISSN： 1911-6470            Impact factor:   1.862


  18 in total

1.  Imaging characteristics of minimal fat renal angiomyolipoma with histologic correlations.

Authors:  Jason Hafron; James D Fogarty; David M Hoenig; Maomi Li; Robert Berkenblit; Reza Ghavamian
Journal:  Urology       Date:  2005-12       Impact factor: 2.649

2.  Melanocyte-marker-HMB-45 is regularly expressed in angiomyolipoma of the kidney.

Authors:  M Pea; F Bonetti; G Zamboni; G Martignoni; M Riva; R Colombari; A Mombello; M Bonzanini; A Scarpa; C Ghimenton
Journal:  Pathology       Date:  1991-07       Impact factor: 5.306

3.  Renal angiomyolipoma with nodal involvement. A 20 year follow up.

Authors:  R Agarwal; P K Agarwal; D Dalela
Journal:  Br J Urol       Date:  1995-10

4.  Angiomyolipoma of the kidney and lymph nodes.

Authors:  T Fröhlich; A Brands; W F Thon; H P Weskott; H Ostertag
Journal:  World J Urol       Date:  1999-04       Impact factor: 4.226

5.  Triphasic and epithelioid minimal fat renal angiomyolipoma and clear cell renal cell carcinoma: qualitative and quantitative CEUS characteristics and distinguishing features.

Authors:  Qing Lu; Cui-xian Li; Bei-jian Huang; Li-yun Xue; Wen-ping Wang
Journal:  Abdom Imaging       Date:  2015-02

6.  Management of angiomyolipoma vena cava thrombus during pregnancy.

Authors:  Jonathan Lopater; Olivier Hartung; Florence Bretelle; Cyrille Bastide
Journal:  Obstet Gynecol       Date:  2011-02       Impact factor: 7.661

Review 7.  EAU guidelines on renal cell carcinoma: 2014 update.

Authors:  Borje Ljungberg; Karim Bensalah; Steven Canfield; Saeed Dabestani; Fabian Hofmann; Milan Hora; Markus A Kuczyk; Thomas Lam; Lorenzo Marconi; Axel S Merseburger; Peter Mulders; Thomas Powles; Michael Staehler; Alessandro Volpe; Axel Bex
Journal:  Eur Urol       Date:  2015-01-21       Impact factor: 20.096

8.  Renal angiomyolipoma: optimal treatment based on size and symptoms.

Authors:  M Dickinson; H Ruckle; M Beaghler; H R Hadley
Journal:  Clin Nephrol       Date:  1998-05       Impact factor: 0.975

9.  Clinical correlates of renal angiomyolipoma subtypes in 209 patients: classic, fat poor, tuberous sclerosis associated and epithelioid.

Authors:  Brian R Lane; Hakan Aydin; Teresa L Danforth; Ming Zhou; Erick M Remer; Andrew C Novick; Steven C Campbell
Journal:  J Urol       Date:  2008-07-16       Impact factor: 7.450

10.  Angiomyolipoma with caval extension and regional nodal involvement: Aggressive behaviour or just rare natural history? Case report and review of literature.

Authors:  Kamaljot Singh Kaler; Rebekah Rittberg; Darrel E Drachenberg
Journal:  Can Urol Assoc J       Date:  2014-03       Impact factor: 1.862
View more
  2 in total

1.  Magnetic resonance imaging features of minimal-fat angiomyolipoma and causes of preoperative misdiagnosis.

Authors:  Xiao-Long Li; Li-Xin Shi; Qi-Cong Du; Wei Wang; Li-Wei Shao; Ying-Wei Wang
Journal:  World J Clin Cases       Date:  2020-06-26       Impact factor: 1.337

Review 2.  Sporadic multiple renal angiomyolipoma with lymph node involvement: a case report and literature review.

Authors:  Xiaobo Ding; Meizi Cui; Tiejun Wang; Helei Wang; Xinyu Wang; Wei Qiu; Yanbo Wang
Journal:  J Int Med Res       Date:  2021-03       Impact factor: 1.671
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.